GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Cyclically Adjusted FCF per Share

Yuhan (XKRX:000100) Cyclically Adjusted FCF per Share : ₩221.31 (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Yuhan's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩-227.263. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩221.31 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Yuhan's average Cyclically Adjusted FCF Growth Rate was -33.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -15.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -19.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Yuhan was -5.90% per year. The lowest was -20.60% per year. And the median was -19.80% per year.

As of today (2024-05-31), Yuhan's current stock price is ₩68800.00. Yuhan's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩221.31. Yuhan's Cyclically Adjusted Price-to-FCF of today is 310.88.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Yuhan was 349.74. The lowest was 28.82. And the median was 80.31.


Yuhan Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Yuhan's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Cyclically Adjusted FCF per Share Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 763.32 463.56 428.05 381.44 282.51

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 332.49 301.59 318.09 282.51 221.31

Competitive Comparison of Yuhan's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Yuhan's Cyclically Adjusted Price-to-FCF falls into.



Yuhan Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yuhan's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-227.263/118.8477*118.8477
=-227.263

Current CPI (Mar. 2024) = 118.8477.

Yuhan Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -73.187 99.353 -87.547
201409 46.188 99.608 55.109
201412 429.698 99.098 515.335
201503 -57.557 99.720 -68.597
201506 687.949 100.050 817.203
201509 -365.517 100.110 -433.931
201512 306.613 100.220 363.603
201603 -817.661 100.560 -966.360
201606 1,085.843 100.790 1,280.384
201609 -536.277 101.460 -628.181
201612 160.848 101.560 188.228
201703 402.096 102.850 464.640
201706 698.181 102.610 808.666
201709 -521.635 103.490 -599.045
201712 268.973 102.990 310.388
201803 184.712 104.100 210.880
201806 760.085 104.130 867.515
201809 -425.426 105.650 -478.570
201812 132.030 104.350 150.373
201903 1,238.650 104.490 1,408.850
201906 -250.838 104.880 -284.244
201909 85.715 105.200 96.835
201912 11.272 105.120 12.744
202003 65.420 105.540 73.669
202006 353.711 104.870 400.856
202009 -977.796 106.200 -1,094.245
202012 -487.667 105.765 -547.987
202103 1,438.431 107.357 1,592.387
202106 -1,153.904 107.579 -1,274.778
202109 -243.731 108.759 -266.339
202112 268.848 109.676 291.329
202203 254.091 111.806 270.094
202206 664.195 114.083 691.936
202209 -900.061 114.831 -931.542
202212 32.633 115.200 33.666
202303 48.204 116.550 49.154
202306 -349.276 117.140 -354.368
202309 -431.368 119.111 -430.414
202312 -67.334 118.848 -67.334
202403 -227.263 118.848 -227.263

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Yuhan  (XKRX:000100) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Yuhan's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=68800.00/221.31
=310.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Yuhan was 349.74. The lowest was 28.82. And the median was 80.31.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Yuhan Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Yuhan's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000100) Business Description

Industry
Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines